RCKT
RCKT
US77313F1066
Rocket Pharmaceuticals, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
228.516.000 273.205.000
16.4%
Operating Income -228.516.000 -273.205.000
16.4%
Pretax Income -223.123.000 -258.746.000
13.8%
Net Income Common Stockholders -223.123.000 -258.746.000
13.8%
-- --
--
-- --
--
ende